FDA expands meningitis vaccine approval

Oct 22, 2007

The U.S. Food and Drug Administration has expanded approval for the use of Menactra, a bacterial meningitis vaccine, to children ages 2 to 10.

Menactra was first approved by the FDA in January 2005 for people ages 11 to 55. The vaccine Menomune was previously the only meningococcal vaccine available in the United States for use in children ages 2 and older, the FDA said Thursday in a release.

Both products are manufactured by Sanofi Pasteur Inc. of Swiftwater, Pa.

Meningitis, a serious inflammation of the lining that surrounds the spinal cord and brain, can cause death or permanent brain injury.

Copyright 2007 by United Press International

Explore further: Supercomputers link proteins to drug side effects

add to favorites email to friend print save as pdf

Related Stories

Designer bacteria may lead to better vaccines

Jan 15, 2013

Researchers at The University of Texas at Austin have developed a menu of 61 new strains of genetically engineered bacteria that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera ...

HPV vaccination prevents genital warts in males

Feb 04, 2011

(PhysOrg.com) -- A new international study shows the human papillomavirus (HPV) vaccine protects against genital warts and other lesions associated with HPV in males. HPV is the most common sexually transmitted disease and ...

Recommended for you

Supercomputers link proteins to drug side effects

1 hour ago

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

9 hours ago

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments : 0